Karyopharm Therapeutics, Inc. (KPTI)
0.0183
-0.02
(-54.25%)
USD |
NASDAQ |
Nov 10, 16:00
0.0163
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Cash from Operations (Annual) : -75.37M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -75.37M |
| December 31, 2024 | -127.49M |
| December 31, 2023 | -92.72M |
| December 31, 2022 | -149.55M |
| December 31, 2021 | -107.12M |
| December 31, 2020 | -160.23M |
| December 31, 2019 | -190.82M |
| December 31, 2018 | -159.12M |
| Date | Value |
|---|---|
| December 31, 2017 | -73.72M |
| December 31, 2016 | -84.39M |
| December 31, 2015 | -94.03M |
| December 31, 2014 | -51.45M |
| December 31, 2013 | -30.29M |
| December 31, 2012 | -15.51M |
| December 31, 2011 | -8.549M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Heron Therapeutics, Inc. | -27.59M |
| Tonix Pharmaceuticals Holding Corp. | -99.84M |
| Minerva Neurosciences, Inc. | -13.51M |
| Corbus Pharmaceuticals Holdings, Inc. | -64.49M |
| Ocugen, Inc. | -56.96M |